The Health Ministers of the EU countries could not agree on the single guidance notes for the use of the AstraZeneca vaccine against Covid-19 as Reuters reported.
The ministers held an extraordinary virtual meeting after the statement of the European Medicines Agency (EMA) on the link between the AstraZeneca vaccine and blood clots. Despite the fact that the Portuguese minister urged the colleagues to develop a single position toward the use of the vaccine, the officials failed to agree on it.
The official EU representative stated that the talks will continue during the next meetings.
“It is essential that we follow a coordinated European approach. An approach which does not confuse citizens, and that does not fuel vaccine hesitancy,” EU Health Commissioner Stella Kyriakides said.
On April 6, the EMA representative confirmed there is a connection between the AstraZeneca vaccine against coronavirus and the development of blood clots in the patients' bodies.
The first messages about side effects after vaccination with AstraZeneca (Vaxzevria) appeared in early March. Austria was the first to state it suspends the vaccination with the use of this drug. Later, more than 20 countries did the same.
Currently, the lethal cases after the AstraZeneca drug were reported by the UK, Norway, Georgia, Germany and other countries.
#Covid latest update (April 8, 9 am, Kyiv time) pic.twitter.com/O2eYDB6Th4
— 112 News (@112NewsFeed) April 8, 2021
